Non-Current Assets
Operating Lease Right-of-Use Assets in Other Assets
Roivant Sciences Operating Lease Right-of-Use Assets in Other Assets decreased by 3.8% to $80.42M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.7%, from $89.02M to $80.42M. Over 5 years (FY 2020 to FY 2025), Operating Lease Right-of-Use Assets in Other Assets shows an upward trend with a 5.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2018
Last reportedQ1 2026
Metric ID:
operating_lease_rou_assets_in_otherHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $65.16M | $63.20M | $61.68M | $61.04M | $59.43M | $53.09M | $54.64M | $53.25M | $51.63M | $48.63M | $46.90M | $44.00M | $45.31M | $42.98M | $90.90M | $89.02M | $87.08M | $85.14M | $83.56M | $80.42M |
| QoQ Change | — | -3.0% | -2.4% | -1.0% | -2.6% | -10.7% | +2.9% | -2.5% | -3.0% | -5.8% | -3.6% | -6.2% | +3.0% | -5.2% | +111.5% | -2.1% | -2.2% | -2.2% | -1.8% | -3.8% |
| YoY Change | — | — | — | — | -8.8% | -16.0% | -11.4% | -12.8% | -13.1% | -8.4% | -14.2% | -17.4% | -12.2% | -11.6% | +93.8% | +102.3% | +92.2% | +98.1% | -8.1% | -9.7% |
Range$42.98M – $90.90M
CAGR+4.5%
Avg YoY Growth+15.2%
Median YoY Growth-10.5%
Current Streak5 quarters decline
Operating Lease Right-of-Use Assets in Other Assets at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's operating lease right-of-use assets in other assets?
- Roivant Sciences (ROIV) reported operating lease right-of-use assets in other assets of $80.42M in Q1 2026.
- How has Roivant Sciences's operating lease right-of-use assets in other assets changed year-over-year?
- Roivant Sciences's operating lease right-of-use assets in other assets decreased by 9.7% year-over-year, from $89.02M to $80.42M.
- What is the long-term trend for Roivant Sciences's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Roivant Sciences's operating lease right-of-use assets in other assets has grown at a 5.2% compound annual growth rate (CAGR), from $62.28M to $80.42M.